Pfizer–BioNTech COVID-19 vaccine
mRNA vaccine against COVID-19 from BioNTech in cooperation with Pfizer
Välised allikad
| WikiProjectMed ID | |
| MeSH descriptor ID | D000090982 teema nimetus kujul: BNT162 Vaccine |
| MeSH tree code | |
| UNII | |
| CAS Registry Number | |
| Australian Register of Therapeutic Goods ID | |
| ATC code | |
| PubChem Substance ID (SID) | |
| VIOLIN ID | |
| World Health Organisation international non-proprietary name numeric ID | |
| European Medicines Agency product number | EMEA/H/C/005735[1] |
| Google Knowledge Graph ID | |
| MedlinePlus drug identifier | |
| RxNorm ID | |
| DrugBank ID | |
| Vaccine Ontology ID |
üksikjuht nähtusest
funded product[2]
funder
World Health Organisation international non-proprietary name
tozinameran
توزيناميران[5]
тозинамеран[6]
托兹奈米瑞[6]
side effect
route of administration
kirjeldatud allikas
Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults[16]
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report[17]
Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine[18]
A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults[19]
Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults[20]
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study[20]
A Phase I clinical trial of novel coronavirus pneumonia (COVID-19) mRNA Vaccine (BNT162b1) in China[19]
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates[18]
NCI Thesaurus ID
C173055
Commonsi kategooria
Tozinameran
Viited
- ↑ 1,0 1,1 Euroopa Ravimiamet, 24. detsember 2020, https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty, EMEA/H/C/005735
- ↑ 2,0 2,1 2,2 2,3 11. juuli 2020, https://covid-19tracker.milkeninstitute.org/
- ↑ https://www.reuters.com/article/idUSKBN2661JB
- ↑ 4,0 4,1 4,2 4,3 WHO Drug Information, https://www.who.int/medicines/publications/druginformation/issues/DrugInformation2020_Vol34-3/en/, 641–685, 3, inglise keel, 23. oktoober 2020, List No. 124 – COVID-19 (Special Edition) of Proposed International Nonproprietary Names (INN) for Pharmaceutical Substances, 34
- ↑ 5,0 5,1 5,2 5,3 5,4 Ravimi geneeriline nimetus, 11889, 20. veebruar 2021, https://mednet-communities.net/inn/db/ViewINN.aspx?i=11889
- ↑ 6,0 6,1 11889
- ↑ https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/anaphylaxis-management.html
- ↑ Suspicions grow that nanoparticles in Pfizer’s COVID-19 vaccine trigger rare allergic reactions
- ↑ https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/pfizer-specific-training_full-deck_19aug.pdf
- ↑ https://www.pfizer.com/products/product-list
- ↑ https://covid-19tracker.milkeninstitute.org/, 12. november 2020
- ↑ https://www.zeit.de/2020/47/biontech-corona-impfstoff-start-up-pandemie, 12. november 2020
- ↑ https://www.aerztezeitung.de/Wirtschaft/In-Marburg-statt-Grippe-Vazine-bald-Produktion-von-Corona-Impfstoff-412953.html, 12. november 2020
- ↑ https://www.reuters.com/article/us-health-coronavirus-vaccines-baxter-in-idUSKBN29I18Y
- ↑ https://www.who.int/publications/i/item/background-document-on-mrna-vaccine-bnt162b2-(pfizer-biontech)-against-covid-19, 4. mai 2021
- ↑ 12. juuli 2020, https://covid-19tracker.milkeninstitute.org/
- ↑ 26. august 2020, https://covid-19tracker.milkeninstitute.org/
- ↑ 18,0 18,1 inferred from abstract
- ↑ 19,0 19,1 https://covid-19tracker.milkeninstitute.org/, 30. august 2020
- ↑ 20,0 20,1 inferred from title
- ↑ aljazeera.com, https://www.aljazeera.com/news/2020/12/15/sputnik-v-what-to-know-about-the-russian-vaccine-in-500-words, inglise keel, 15. detsember 2020, Sputnik V: What to know about the Russian vaccine, in 500 words
- ↑ Politico Europe, https://www.politico.eu/article/belgian-secretary-of-state-accidentally-reveals-eu-vaccine-prices/, inglise keel, 17. detsember 2020, Belgian secretary of state accidentally reveals EU vaccine prices